chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Biopsy, Headache, Heart rate increased, Neck pain
Clinical narrative: vaginal bleeding after approximately 12 years post menopause; abdominal pain; severe headache; neck pain; Periodic heart rate increase.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 66-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0179, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 05May2021 at 15:30 pm (age at vaccination was 66 years) as dose 1, single for COVID-19 immunization. Medical history included hypothyroidism, atrial flutter, ablation surgery and menopause (age 51). Concomitant medications the patient received within 2 weeks of vaccination included thyroid (ARMOUR THYROID) and acetylsalicylic acid (ASPIRIN) both taken for an unspecified indication. The patient previously took amoxicillin, codeine and nizoral for allergy. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 06May2021, the day after injection, the patient experienced severe headache and neck pain for several days. On an unspecified date in June2021, the patient experienced abdominal pain and vaginal bleeding after approximately 12 years post-menopausal no bleeding. On an unspecified date in 2021, the patient experienced periodic heart rate increase. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with Tylenol for neck and headache. The patient underwent lab tests which included pap test and biopsy with unknown results on an unspecified date. Since the vaccination, the patient has tested for COVID-19. The patient underwent lab tests which included SARS CoV-2 test (other): negative on 24May2021. The outcome of the events severe headache and neck pain was not resolved. The outcome of the other events was unknown.   Follow-up attempts are completed. No further information is expected.  Follow-up (16Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Smear cervix, Vaginal haemorrhage
Clinical narrative: vaginal bleeding after approximately 12 years post menopause; abdominal pain; severe headache; neck pain; Periodic heart rate increase.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 66-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0179, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 05May2021 at 15:30 pm (age at vaccination was 66 years) as dose 1, single for COVID-19 immunization. Medical history included hypothyroidism, atrial flutter, ablation surgery and menopause (age 51). Concomitant medications the patient received within 2 weeks of vaccination included thyroid (ARMOUR THYROID) and acetylsalicylic acid (ASPIRIN) both taken for an unspecified indication. The patient previously took amoxicillin, codeine and nizoral for allergy. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 06May2021, the day after injection, the patient experienced severe headache and neck pain for several days. On an unspecified date in June2021, the patient experienced abdominal pain and vaginal bleeding after approximately 12 years post-menopausal no bleeding. On an unspecified date in 2021, the patient experienced periodic heart rate increase. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with Tylenol for neck and headache. The patient underwent lab tests which included pap test and biopsy with unknown results on an unspecified date. Since the vaccination, the patient has tested for COVID-19. The patient underwent lab tests which included SARS CoV-2 test (other): negative on 24May2021. The outcome of the events severe headache and neck pain was not resolved. The outcome of the other events was unknown.   Follow-up attempts are completed. No further information is expected.  Follow-up (16Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood pressure decreased, Blood pressure measurement, Dizziness, Fall
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Feeling abnormal, Feeling cold, Headache, Herpes zoster, Hyperhidrosis
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vomiting
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood pressure measurement, Cold sweat, Fatigue, Hypotension
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Malaise, Salivary hypersecretion
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Hyperhidrosis, Hypotension
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Cold sweat, Hypoaesthesia
Clinical narrative: Cold sweat forehead dripping; B/P taken 107/70; Extra Slavia that foamed in mouth; Feeling unwell; Weakness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN). The patient previously took aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the patient experienced cold sweat forehead dripping, low blood pressure blood pressure taken 107/70 and on standing 133/80, fatigue for 2 weeks, despite full night sleep along with weakness for 2 weeks, extra saliva that foamed in mouth for 10 days and feeling unwell for 2 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received water and was made to stand as treatment for the low blood pressure. The patient did not receive any treatment for other events. The clinical outcome of the events cold sweat forehead dripping, low blood pressure, fatigue, weakness, extra saliva formation and feeling unwell was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient died of a massive heart attack less than 18 hours after receiving the shot. When I awoke around 4:30am on 4/14, he was already dezd.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Myocardial infarction
Clinical narrative: Patient died of a massive heart attack less than 18 hours after receiving the shot. When I awoke around 4:30am on 4/14, he was already dezd.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Electromyogram, Guillain-Barre syndrome, Hypoaesthesia, Immunology test
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody negative, Blood folate normal, Blood thyroid stimulating hormone normal, Burning sensation, CSF protein normal
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF test normal, Differential white blood cell count, Discomfort, Electromyogram abnormal, Electrophoresis protein normal
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fine motor skill dysfunction, Full blood count, Glycosylated haemoglobin normal, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyporeflexia, Immunoglobulin therapy, Limb discomfort, Mean cell volume increased, Metabolic function test
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Motor dysfunction, Pain, Pain in extremity, Paraesthesia, Red blood cell sedimentation rate increased
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thyroxine free normal, Vitamin B12 normal, Vitamin D decreased
Clinical narrative: acute inflammatory demyelinating polyradiculoneuropathy (AIDP, aka Guillain-Barre Syndrome)  treated with IVIG 5/14-5/17/21: sudden onset noting numbness in fingers and toes around 4/13/21 and 4/14/21 and about 10 days later saw Primary Care for evaluation, but since this time notes progression of symptoms up to knee and forearm level. He also notes loss of fine motor abilities due to reduced sensation, and also has difficulty holding a pen to write. He notes development of loss of reflexes over this time period. Notes tingling sensation in hands and feels as if walking on rocks on feet and feels as if everything is tight, also notes burning pains and discomfort even with touching keyboard. No diarrheal illness, no change to bowel habits.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Echocardiogram abnormal, Magnetic resonance imaging, Myocarditis, Palpitations
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Positron emission tomogram
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase MB normal, C-reactive protein normal, Cardiac imaging procedure abnormal, Dyspnoea exertional, Echocardiogram
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram QRS complex abnormal, Electrocardiogram QT prolonged, Electrocardiogram ST segment abnormal
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Left atrial enlargement, Left ventricular enlargement, Lethargy, Magnetic resonance imaging heart
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mitral valve incompetence, Mitral valve prolapse, Myocardial oedema, Myocarditis, N-terminal prohormone brain natriuretic peptide increased
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Pericardial effusion, Red blood cell sedimentation rate normal, Right ventricular ejection fraction decreased, Sinus bradycardia
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin normal, Ventricular extrasystoles, Ventricular hypokinesia
Clinical narrative: Dx: Myocarditis S/S: Lethargy/Fatigue,  Dyspnea on exertion, onset  02/13/2021 Possible alternative diagnosis: Prolonged number of visits for PVCs, etc.  Patient seen in ED 3 times 3/2/21, 3/11/21 and 3/18/21 for palpitations.  Discharged each time without dx of myo or pericarditis.      Seen outpt cardiology 3/15.  More extensive workup planned but diagnosis of PVCs and QT prolongation by ECG.  Troponin negative.  ECHO 3/17     1. Left ventricular ejection fraction, by visual estimation, is 45%   with diffuse hypokinesis and frequent PVCs.   2. Mild mitral valve prolapse.   3. Mild mitral valve regurgitation.    Seen again in Cardiology 3/25.  Had CMRI 3/24.  CMRI in abstract above diagnosis made    Add Hx:  She reports that she had forgotten that she was very sick with a viral infection in the end of January 2021.  She had got Covid tested at that time twice the results of both were negative.     Moderna 1.8 and 2.4  had "viral infection " late Jan but dx myocarditis March after presenting with palpitations
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Wrong product administered
Clinical narrative: Pt inadvertently given Moderna vaccine as a 1st dose on 4/29/21 then Pfizer vaccine as a 2nd dose on 6/3/21
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Pt inadvertently given Moderna vaccine as a 1st dose on 4/29/21 then Pfizer vaccine as a 2nd dose on 6/3/21
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Generalised tonic-clonic seizure
Clinical narrative: Increase in Tonic Clonic seizures,; A total of 6 seizures which are ongoing to this day; This is a spontaneous report from a contactable consumer (patient herself). A 26-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Lot number: EW0175, Expiration Date was not reported), via an unspecified route of administration in right arm on 29Apr2021 11:15 (at the age of 26-years-old) as dose 1, single for COVID-19 immunisation. The patient medical history included epilepsy, ADHD. Concomitant medication included zonisamide, methylphenidate hydrochloride (CONCERTA), folic acid (FOLIC), all taken for unknown indications from an unknown date. Other medications received in two weeks included Kelnor birth control. The patient previously took celontin and experienced drug hypersensitivity. No other vaccine received in fou rweeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not tested for COVID-19 since the vaccination. On 29Apr2021 03:00 PM, the patient experienced increase in tonic clonic seizures, A total of 6 seizures which are ongoing to this day. Treatment was received for the events. Adverse event treatment includes rescue medication. The outcome of the events was unknown.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Generalised tonic-clonic seizure, Seizure
Clinical narrative: Increase in Tonic Clonic seizures,; A total of 6 seizures which are ongoing to this day; This is a spontaneous report from a contactable consumer (patient herself). A 26-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Lot number: EW0175, Expiration Date was not reported), via an unspecified route of administration in right arm on 29Apr2021 11:15 (at the age of 26-years-old) as dose 1, single for COVID-19 immunisation. The patient medical history included epilepsy, ADHD. Concomitant medication included zonisamide, methylphenidate hydrochloride (CONCERTA), folic acid (FOLIC), all taken for unknown indications from an unknown date. Other medications received in two weeks included Kelnor birth control. The patient previously took celontin and experienced drug hypersensitivity. No other vaccine received in fou rweeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not tested for COVID-19 since the vaccination. On 29Apr2021 03:00 PM, the patient experienced increase in tonic clonic seizures, A total of 6 seizures which are ongoing to this day. Treatment was received for the events. Adverse event treatment includes rescue medication. The outcome of the events was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Joint range of motion decreased, Muscle spasms
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Oedema, SARS-CoV-2 test negative
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody, Arthralgia, Asthenia, Blood creatine phosphokinase normal, Borrelia test negative
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein normal, Condition aggravated, Electrophoresis protein, Fatigue, Feeling hot
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Joint swelling, Laboratory test, Mobility decreased, Motor dysfunction, Myalgia
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Posture abnormal, Rheumatoid factor
Clinical narrative: Endorses significant painful swelling of multiple joints including hands, wrists, legs, ankles, decreased mobility of the small joints of her extremities.  Symptoms worsened after the second dose of the vaccination. Since then, her symptoms have worsened.  Endorses hand swelling daily, worse overnight and in the mornings.  States that she wakes up with her hands paralyzed into a claw position, painful, right worse than left.  Endorses fatigue, myalgias, weakness.  States her fingers feel that they are on fire.  Is starting to drop things -having difficulty with sustaining grasp and having difficulty writing.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Erythema, Neck pain
Clinical narrative: Shortness of breath; dizziness,; weakness,; neck pain; redness of the face and neck; This is a spontaneous report from a contactable consumer (patient self).  A 53-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 28Jun2021 10:00 (Batch/Lot number was not reported) (at the age of 53-year-old, not pregnant) as dose 1, single for COVID-19 immunization.  The patient medical history was not reported.   There were no concomitant medications.  There were not any other medications the patient received within 2 weeks of vaccination.  The patient previously took percocet [oxycodone hydrochloride;paracetamol] and experienced allergy.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19.  Facility where the most recent COVID-19 vaccine was administered in hospital.  The patient experienced shortness of breath (seriousness criteria reported as medically significant), dizziness, weakness, neck pain, redness of the face and neck on 28Jun2021 10:30 and resulted in emergency room/department or urgent care.  Treatment included Benadryl 50 mg -Pepcid -Medrol.  Outcome of the events was recovering.  Information on Lot/Batch information has been requested.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Amnesia, Condition aggravated
Clinical narrative: couldn't even remember what he have had for breakfast.; It's effecting his work and daily life was not the same; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received BNT162B2 (COVID-19 MRNA VACCINE BIONTECH), the second dose via unspecified route of administration in left arm on 13May2021 (lot number: EN5318) at single dose for COVID-19 immunization. The relevant medical history included Bipolar 1/PTSD (Post-traumatic stress disorder) from unspecified date. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (first dose, lot number: ER8731, vaccine location: Left arm) on 22Apr2021 at the age of 28 years old for COVID-19 Immunization and experienced memory impairment. At the time of the report the patient couldn't even remember what he had had for breakfast. It's effecting his work and daily life was not the same. No treatment received for the events. The events were reported as serious due to disability. The outcome of the event couldn't even remember what he have had for breakfast was not recovered, while the other event was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Memory impairment, Quality of life decreased
Clinical narrative: couldn't even remember what he have had for breakfast.; It's effecting his work and daily life was not the same; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received BNT162B2 (COVID-19 MRNA VACCINE BIONTECH), the second dose via unspecified route of administration in left arm on 13May2021 (lot number: EN5318) at single dose for COVID-19 immunization. The relevant medical history included Bipolar 1/PTSD (Post-traumatic stress disorder) from unspecified date. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (first dose, lot number: ER8731, vaccine location: Left arm) on 22Apr2021 at the age of 28 years old for COVID-19 Immunization and experienced memory impairment. At the time of the report the patient couldn't even remember what he had had for breakfast. It's effecting his work and daily life was not the same. No treatment received for the events. The events were reported as serious due to disability. The outcome of the event couldn't even remember what he have had for breakfast was not recovered, while the other event was unknown.  Follow-up attempts are completed. No further information is expected.